Cargando…
Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes
This international, randomized, double‐blind trial (NCT01864174) compared the efficacy and safety of metformin extended‐release (XR) and immediate‐release (IR) in patients with type 2 diabetes. After a 4‐week placebo lead‐in, pharmacotherapy‐naïve adults with glycated haemoglobin (HbA1c) at 7.0% to...
Autores principales: | Aggarwal, Naresh, Singla, Anuj, Mathieu, Chantal, Montanya, Eduard, Pfeiffer, Andreas F. H., Johnsson, Eva, Zhao, June, Iqbal, Nayyar, Bailey, Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813139/ https://www.ncbi.nlm.nih.gov/pubmed/28857388 http://dx.doi.org/10.1111/dom.13104 |
Ejemplares similares
-
Reactive Hypoglycemia From Metformin Immediate-Release Monotherapy Resolved by a Switch to Metformin Extended-Release: Conceptualizing Their Concentration-Time Curves
por: Akram, Ayesha
Publicado: (2021) -
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post‐hoc analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin
por: Del Prato, Stefano, et al.
Publicado: (2018) -
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
por: Tan, Jixue, et al.
Publicado: (2021) -
Head‐to‐Head Comparison of Selected Extra‐ and Intracellular CO‐Releasing Molecules on Their CO‐Releasing and Anti‐Inflammatory Properties
por: Li, Yingchun, et al.
Publicado: (2021) -
Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
por: Mitrevska, Ivana, et al.
Publicado: (2019)